Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: john dixon who wrote (3109)	5/26/1999 9:28:00 AM
From: EZLibra	Read Replies (1) \| Respond to of 3702

Thanks Roger and John. I think there is a high probability Cotara will be cleared for accelerated approval in brain cancers. I am confused as to what the time frame is, whether it was 60 days and an FDA decision or 60 days to be told what is required for a decision. Regardless of the time frame I think approval will result in a tidal wave of new therapy for cancer victims. Remember TNT showed efficacy by IV, intrathecal, and post-surgery delivery in the China trial. The oncodocs are in charge, not Big Pharma. You're right about the Redskins, John, greedy management wanted my TCLN shares too. I told them that was one kicker they couldn't afford.